Bertilimumab

BIOLOGICAL2 trials

Sponsors

Alexion Pharmaceuticals, Inc.

Conditions

Pemphigoid, BullousUlcerative Colitis, Active ModerateUlcerative Colitis, Active Severe

Phase 2

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

TerminatedNCT01671956

Alexion Pharmaceuticals, Inc.Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe

Start: 2015-07-31End: 2018-11-14Updated: 2025-11-25

Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

CompletedNCT02226146

Alexion Pharmaceuticals, Inc.Pemphigoid, Bullous

Start: 2016-02-29End: 2018-04-30Updated: 2025-11-26